HER2-targeted advanced metastatic gastric/gastroesophageal junction adenocarcinoma: treatment landscape and future perspectives

Recently, the global incidence of gastric/gastroesophageal junction (G/GEJ) cancer has remained high. China is also a large country with a high gastric cancer (GC) incidence rate, where the cases of GC account for 40% of all cases worldwide. More than 90% of GEJ cancers are the adenocarcinoma pathol...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Weiling, Zhang, Xiaoling, Du, Yunyi, Zhang, Ying, Lu, Jing, Hu, Wenqing, Zhao, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524015/
https://www.ncbi.nlm.nih.gov/pubmed/36175985
http://dx.doi.org/10.1186/s40364-022-00416-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524015/
https://www.ncbi.nlm.nih.gov/pubmed/36175985
http://dx.doi.org/10.1186/s40364-022-00416-x

Ejemplares similares